25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2.
Age Factors
Aged
Aged, 80 and over
Betacoronavirus
/ isolation & purification
COVID-19
Coronavirus Infections
/ blood
Dietary Supplements
Female
Humans
Male
Middle Aged
Pandemics
Pneumonia, Viral
/ blood
Polymerase Chain Reaction
Retrospective Studies
SARS-CoV-2
Switzerland
Vitamin D
/ administration & dosage
COVID-19
SARS-CoV-2
concentrations
coronavirus
deficiency
vitamin D
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
09 May 2020
09 May 2020
Historique:
received:
20
04
2020
revised:
06
05
2020
accepted:
07
05
2020
entrez:
14
5
2020
pubmed:
14
5
2020
medline:
15
5
2020
Statut:
epublish
Résumé
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), with a clinical outcome ranging from mild to severe, including death. To date, it is unclear why some patients develop severe symptoms. Many authors have suggested the involvement of vitamin D in reducing the risk of infections; thus, we retrospectively investigated the 25-hydroxyvitamin D (25(OH)D) concentrations in plasma obtained from a cohort of patients from Switzerland. In this cohort, significantly lower 25(OH)D levels (
Identifiants
pubmed: 32397511
pii: nu12051359
doi: 10.3390/nu12051359
pmc: PMC7285131
pii:
doi:
Substances chimiques
Vitamin D
1406-16-2
25-hydroxyvitamin D
A288AR3C9H
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Inflamm Bowel Dis. 2019 May 4;25(6):1088-1095
pubmed: 30601999
Cureus. 2020 Apr 6;12(4):e7560
pubmed: 32269893
Ir Med J. 2020 Apr 03;113(4):58
pubmed: 32268051
Aliment Pharmacol Ther. 2020 May;51(10):993-995
pubmed: 32281109
J Infect. 2020 Jun;80(6):656-665
pubmed: 32283155
Ir Med J. 2020 Apr 03;113(4):64
pubmed: 32268052
Nutrients. 2020 Apr 02;12(4):
pubmed: 32252338